Company Performance - Doximity (DOCS) closed at $73.60, with a daily increase of +1.28%, outperforming the S&P 500's gain of 0.48% [1] - The stock has risen by 12.91% over the past month, leading the Medical sector's gain of 1.09% and the S&P 500's gain of 2.46% [1] Upcoming Earnings - Doximity is expected to report EPS of $0.38, reflecting a 26.67% increase from the prior-year quarter [2] - The projected revenue for the upcoming earnings is $157.73 million, up 15.27% from the year-ago period [2] Fiscal Year Estimates - For the entire fiscal year, earnings are estimated at $1.5 per share, indicating a +5.63% change from the previous year [3] - Revenue for the fiscal year is projected at $632.56 million, showing a +10.9% increase from the prior year [3] Analyst Estimates - Investors should monitor changes in analyst estimates for Doximity, as positive revisions indicate confidence in business performance [4] - Estimate revisions are correlated with near-term share price momentum, which can be leveraged for investment strategies [5] Zacks Rank and Valuation - Doximity currently holds a Zacks Rank of 3 (Hold), with no changes in the EPS estimate over the past month [6] - The company has a Forward P/E ratio of 48.38, which is higher than the industry average of 38.89 [7] - Doximity's PEG ratio stands at 3.52, compared to the industry average PEG ratio of 3.28 [7] Industry Overview - The Medical Info Systems industry, part of the Medical sector, has a Zacks Industry Rank of 68, placing it in the top 28% of over 250 industries [8] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1, indicating a favorable environment for investment [8]

Company Performance - Doximity's stock closed at $59.70, down 2.13% from the previous trading session, underperforming the S&P 500's loss of 0.3% [1] - The stock has decreased by 0.55% over the past month, while the Medical sector gained 0.76% and the S&P 500 increased by 3.64% [1] Earnings Forecast - Doximity is expected to release its earnings on August 7, 2025, with projected earnings per share (EPS) of $0.31, reflecting a 10.71% increase year-over-year [2] - Revenue is forecasted to be $139.67 million, indicating a 10.26% growth compared to the same quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of $1.46 per share and revenue of $625.72 million, representing increases of 2.82% and 9.7% respectively from the previous year [3] Analyst Revisions - Recent changes in analyst estimates for Doximity are important as they reflect short-term business trends, with positive revisions indicating a favorable business outlook [3][4] Zacks Rank - Doximity currently holds a Zacks Rank of 1 (Strong Buy), which has historically outperformed with an average annual return of +25% since 1988 [5] - The Zacks Consensus EPS estimate has remained steady over the past month [5] Valuation Metrics - Doximity has a Forward P/E ratio of 41.81, which is a premium compared to the industry average of 27.27 [6] - The company has a PEG ratio of 4.54, while the average PEG ratio for the Medical Info Systems industry is 2.66 [6] Industry Context - The Medical Info Systems industry ranks in the top 23% of all industries, with a current Zacks Industry Rank of 55 [7] - Strong individual industry groups, as measured by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [7]

Company Performance - Doximity's stock (DOCS) decreased by 1.44% to $59.38, underperforming the S&P 500's daily gain of 0.06% [1] - Over the past month, Doximity's stock has increased by 3.92%, while the Medical sector has declined by 1.83% and the S&P 500 has risen by 5.88% [1] Earnings Forecast - Doximity is expected to release its earnings on August 7, 2025, with a forecasted EPS of $0.31, reflecting a 10.71% increase from the same quarter last year [2] - Revenue is projected to be $139.67 million, indicating a 10.26% growth compared to the corresponding quarter of the previous year [2] Full-Year Estimates - The Zacks Consensus Estimates for Doximity's full-year earnings are $1.46 per share and revenue of $625.72 million, representing year-over-year changes of +2.82% and +9.7%, respectively [3] - Recent adjustments to analyst estimates suggest evolving short-term business trends, with positive revisions indicating analyst optimism [3] Valuation Metrics - Doximity has a Forward P/E ratio of 41.3, which is higher than the industry average of 28.27 [6] - The company also has a PEG ratio of 4.48, compared to the Medical Info Systems industry's average PEG ratio of 3.23 [6] Industry Ranking - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 81, placing it in the top 33% of over 250 industries [7] - The Zacks Industry Rank is based on the average Zacks Rank of individual stocks within the industry, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Company Performance - Doximity (DOCS) closed at $61.09, with a +1.13% change from the previous day, outperforming the S&P 500's gain of 0.52% [1] - The stock has increased by 16.31% over the past month, significantly surpassing the Medical sector's gain of 3.5% and the S&P 500's gain of 5.95% [1] Upcoming Earnings Report - Doximity is expected to report an EPS of $0.31, reflecting a 10.71% increase from the same quarter last year [2] - Revenue is forecasted at $139.67 million, indicating a 10.26% rise compared to the same quarter last year [2] Full Year Projections - For the full year, earnings are projected at $1.46 per share, with a revenue estimate of $625.72 million, showing increases of +2.82% and +9.7% respectively from the previous year [3] Analyst Estimates and Confidence - Recent changes in analyst estimates for Doximity are important as they reflect near-term business trends, with positive revisions indicating analysts' confidence in the company's performance [3][4] Zacks Rank and Performance - Doximity currently holds a Zacks Rank of 3 (Hold), with a consensus EPS projection that has increased by 0.5% in the past 30 days [5] - The Zacks Rank system has a proven track record of outperformance, with 1 stocks returning an average of +25% annually since 1988 [5] Valuation Metrics - Doximity has a Forward P/E ratio of 41.41, which is a premium compared to the industry average Forward P/E of 32.04 [6] - The company has a PEG ratio of 4.49, higher than the industry average PEG ratio of 2.75 [7] Industry Ranking - The Medical Info Systems industry, to which Doximity belongs, ranks in the top 31% of all industries, with a current Zacks Industry Rank of 74 [7]